|
|
GPS Device Can Measure Walking Capacity in PAD Patients
|
| Link ID |
3150 |
| Title |
GPS Device Can Measure Walking Capacity in PAD Patients |
| Url |
http://www.medscape.com/viewarticle/569990?src=rss |
| Description |
Walking capacity measured by a low-cost global-positioning system is highly correlated with the maximal walking distance recorded on an exercise treadmill, a new study has shown. These findings, say investigators, open new avenues in the study of walking capacity for vascular patients or for physicians who do not have a treadmill. Heartwire |
| Category |
Articles > Cardiology |
| Keywords |
|
| Date |
Feb 12, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Cardiology |
| 1. |
Stress Cardiac MR Imaging Useful in Post MI Testing
|
|
|
Adenosine-stress cardiac magnetic resonance (CMR) perfusion imaging is more accurate than standard exercise tolerance testing (ETT) in some aspects of evaluating patients early after acute ST-elevation MI, according to UK researchers. Reuters Health Information
|
| 2. |
World Needs to ENDORSE Better VTE Prevention
|
|
|
A large international trial shows that prophylaxis for venous thromboembolism in the acute hospital care setting is substantially underused worldwide. One of the main reasons for this is the reluctance of some doctors to recognize the benefits of VTE prevention--either because of their specialty or because of where they live, say the researchers. Heartwire
|
| 3. |
Heart Failure Preliminarily Linked to Bone Fractures
|
|
|
Patients diagnosed with heart failure in the emergency department are 4 times as likely to sustain serious bone fractures during the next year vs patients with other cardiovascular disorders. Medscape Medical News
|
| 4. |
Earlier and More Aggressive LDL Lowering, or Better Approaches for Targeting High-Risk Individuals?
|
|
|
A review by three renowned experts in cardiology suggests that efforts to treat elevated cholesterol levels are not exploiting the full potential of cholesterol-lowering strategies and current approaches to treatment are simply doing "too little, too late." Two experts, however, say the review ignores practical issues and other markers that are better able to identify high-risk individuals. Heartwire
|
|
|
